the use of targeted drug therapy for aggressive lymphoma
Published 4 days ago • 32 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
2:15
vipor: a multi-targeted therapy for the treatment of r/r dlbcl
-
1:04
the potential of targeted therapy in dlbcl: open questions
-
2:08
cellular and targeted therapies for hodgkin lymphoma
-
2:26
insights into the future of aml therapy: the increasing use of targeted agents
-
0:42
targeted therapies for dlbcl treatment
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
22:35
haploid induction and breeding : by dr. william rooney
-
4:46
glofitamab induces durable complete remissions in patients with relapsed large b-cell lymphoma
-
1:43
the role of targeted therapies in the frontline treatment of mantle cell lymphoma
-
10:51
update of targeted or chemotherapy-free therapies in lymphoma
-
2:13
specifying which patients should undergo cardiovascular surveillance following lymphoma treatment
-
3:04
applying molecular understanding of dlbcl to management strategies
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
2:40
phase ii study of glofitamab in patients with r/r lbcl
-
1:24
novel agents for the treatment of hodgkin lymphoma: brentuximab vedotin and nivolumab
-
3:16
the role of stem cell transplantation in the era of targeted therapies in dlbcl and mcl
-
2:02
the use of tafasitamab in dlbcl
-
1:02
maintenance therapy following treatment for amyloidosis
-
1:36
targeted therapy for aml